Hexalen · DIN 02126230 · 50 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2013-09-09 — choose a marketed DIN from the same-category list.Discontinued September 9, 2013 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2013-09-09 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2013-09-09 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Hexalen · DIN 02126230
Manufacturer: Eli Lilly Canada Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2013-09-09 · brand HEXALEN · ATC L01XX03 ALTRETAMINE · form Capsule · route Oral · ingredients ALTRETAMINE 50 MG · company Eisai inc · schedule Prescription
Hexalen: Formulary list price $3.36 per unit (the source does not state the unit; exact figure $3.3600). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02126230)
Source record
DIN 02126230: Hexalen
Raw flags: sec3=Y
Item: 100000095; group id 143; item number 0242; lccId None; manufacturer id LIL
Source form: Cap; strength: 50mg
Recorded listing: General benefit
Source prices (unrounded): $3.3600; ministry $3.3600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02126230
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18669
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02126230
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since September 9, 2013 — choose a marketed DIN from the same-category list.